Jean-christophe Cuvellier

Lille, FR 
Lille, FR 

Overview

Jean-christophe Cuvellier practices practicing medicine in Lille, France.

His clinical expertise encompasses Headache, Migraine, Sporadic Hemiplegic Migraine, and Alternating Hemiplegia of Childhood.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Lille, 59037, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
View 2 Less Clinical Trials

10 Total Publications

Hemiplegic Migraine Associated With PRRT2 Variations: A Clinical and Genetic Study.
Hemiplegic Migraine Associated With PRRT2 Variations: A Clinical and Genetic Study.
Journal: Neurology
Published: April 29, 2021

Frequently Asked Questions about Jean-christophe Cuvellier

Is Jean-christophe Cuvellier a top-rated expert for Headache?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-christophe Cuvellier is classified as an Experienced expert for Headache, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-christophe Cuvellier participate in research or clinical trials?

Yes. Jean-christophe Cuvellier has published 10 articles and abstracts on conditions like Headache. You can view a list of Jean-christophe Cuvellier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cuvellier's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile